tirzepatide weight management Loss Injections Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah

10.1021/jf100149w 355

As an inducer of ferroptosis, inhibiting CHAC1-induced cell death may also hold therapeutic relevance for conditions like neurodegenerative diseases

Additionally, GLP-1 medications can cause nausea or vomiting in the immediate postoperative period, which your surgical team will monitor closely

Filippatos T

HW TIPS TO MINIMIZE GI SIDE EFFECTS One or more gastrointestinal (GI) side effects are observed in roughly 10% to 50% of people who take one of these weight management medications.1,2 From nausea and vomiting to acid reflux, bloating, stomach cramps, diarrhea, and/or constipation, patients can minimize GI side effects with a start low, go slow approach, starting with the lowest dose and titrating as recommended (see table Currently FDA-Approved Mono and Dual Agonists)